XM Amerika Qoʻshma Shtatlari fuqarolariga xizmat koʻrsatmaydi.

Teleflex beats quarterly profit estimates on healthy demand for medical devices



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>Teleflex beats quarterly profit estimates on healthy demand for medical devices</title></head><body>

May 2 (Reuters) -Teleflex TFX.N reported a better-than-expected first-quarter profit on Thursday, on the back of strong demand for its medical devices.

The Wayne, Pennsylvania-based company also raised the lower end of its 2024 adjusted profit forecast to $13.60 from $13.55 per share, keeping the upper end at $13.95 per share.

Analysts on average estimate adjusted profit for the period to be $13.73 per share, according to LSEG data.

Investor expectations around the performance of medical device makers have been heightened since last November due to higher demand for procedures, especially among older adults, that were delayed during the COVID-19 pandemic.

Rivals such as Boston Scientific BSX.N and Stryker SYK.N raised their full-year profit forecasts on resilient demand for medical devices, with industry bellwether Johnson & Johnson JNJ.N expecting medtech-related procedures to remain elevated in 2024.

"We are pleased with our solid start to 2024...Our first quarter performance, combined with an improving macro-environment, keeps us well-positioned to deliver on our financial guidance for 2024," said CEO Liam Kelly.

Themanufacturer of hospital supplies and single-use medical devices reported 3.8% rise in revenue from a year ago to $737.9 million for the quarter, higher than Wall Street estimates of $726.9 million.

The company's vascular access segment, its largest, which makes medical devices for bloodstream-related procedures like catheters and probes, reported revenue of $181.4 million, missing estimates of $183.8 million.

Its interventional unit, which focuses on heart and medical imaging devices, reported sales of $134.7 million, above estimates of $125.2 million.

On an adjusted basis, the company reported a profit of $3.21 per share, topping analysts' average estimate of $3.07 per share.



Reporting by Puyaan Singh in Bengaluru; Editing by Vijay Kishore

</body></html>

Javobgarlikdan voz kechish: XM Group korxonalari har biri faqat ijro xizmatlarini koʻrsatadi va onlayn savdo platformamizdan foydalanish huquqini beradi, bu odamga veb-saytda yoki veb-sayt orqali mavjud boʻlgan kontentni koʻrish va/yoki undan foydalanishga ruxsat beradi hamda uni oʻzgartirishga moʻljallanmagan va uni oʻzgartirmaydi yoki kengaytirmaydi. Bunday kirish va foydalanish huquqi doimo quyidagilarga boʻysunadi: (i) Shartlar va qoidalar; (ii) Risklar haqida ogohlantirish; va (iii) Javobgarlikni toʻliq rad etish. Shuning uchun bunday kontent umumiy maʼlumot sifatida taqdim etiladi. Xususan, shuni esda tutingki, bizning onlayn savdo platformamiz mazmuni moliyaviy bozorlarda biror bitimni amalga oshirishga oid maslahat yoki taklif emas. Har qanday moliyaviy bozorda savdo qilish sizning kapitalingiz uchun jiddiy risk darajasini oʻz ichiga oladi.

Onlayn savdo platformamizda chop etilgan barcha materiallar faqat taʼlim/axborot maqsadlari uchun moʻljallangan va unda moliyaviy, investitsiya soligʻi yoki savdo maslahatlari va tavsiyalar; yoki bizning savdo narxlarimizning qaydlari; yoki har qanday moliyaviy vositalar bilan bitim tuzish maslahati yoki taklifi; yoki sizga kerak boʻlmagan moliyaviy reklama aksiyalari hisoblanmaydi

Har qanday uchinchi tomon kontenti, shuningdek XM tomonidan tayyorlangan kontent, masalan: fikrlar, yangiliklar, tadqiqotlar, tahlillar, narxlar va boshqa maʼlumotlar yoki bu veb-saytda joylashgan uchinchi tomon saytlariga havolalar umumiy bozor sharhi sifatida "boricha" taqdim etiladi va investitsiya maslahatini tashkil etmaydi. Har qanday kontent investitsiya tadqiqoti sifatida talqin qilinsa, siz bunday kontentni investitsiya tadqiqotlarining mustaqilligini ragʻbatlantirish uchun moʻljallangan qonun talablariga muvofiq moʻljallanmagan va tayyorlanmaganligini eʼtiborga olishingiz va qabul qilishingiz kerak, shuning uchun unga tegishli qonunlar va qoidalarga muvofiq marketing kommunikatsiyasi sifatida qaraladi. Mustaqil boʻlmagan investitsiya tadqiqoti va yuqoridagi maʼlumotlarga oid risk haqida ogohlantirishimizni oʻqib chiqqaningizga va tushunganingizga ishonch hosil qiling, unga bu yerdan kirish mumkin.

Riskdan ogohlantirish: Kapitalingiz risk ostida. Kredit yordamiga ega mahsulotlar hammaga ham toʻgʻri kelmasligi mumkin. Bizning Risklardan ogohlantirishimiz bilan tanishib chiqing.